COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

27,137 Articles (20,397 medRxiv, 6,740 bioRxiv)

Most recent first Previous |  Page 2015: Articles 20141-20150  | Next

Trends in Angiotensin Receptor Blocker Use Among those at Risk for COVID-19 Morbidity and Mortality in the United States
Perez, A., Speth, R., Saavedra, J.
10.1101/2020.07.24.20161851 — Posted: 2020-07-27
Power Law in COVID-19 Cases in China
Ahundjanov, B. B., Akhundjanov, S. B., Okhunjanov, B. B.
10.1101/2020.07.25.20161984 — Posted: 2020-07-27
Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for IgG antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay
Marien, J., Michiels, J., Heyndrickx, L., Kerkhof, K., Foque, N., Widdowson, M.-A., Desombere, I., Jansens, H., Van Esbroeck, M., Arien, K. K.
10.1101/2020.07.25.20161943 — Posted: 2020-07-27
Impact of COronaVirus Disease -2019 (COVID-19) pandemic on Haemodialysis care delivery pattern in Karnataka, India- a cross-sectional, questionnaire based survey.
Y J, A., Conjeevaram, A., Prabhu A, R., Doshetty, M., Srinivasa, S., Moger, V.
10.1101/2020.07.25.20151225 — Posted: 2020-07-27
Safety and Efficacy Concerns of Lopinavir/Ritonavir in COVID-19 Affected Patients: A Retrospective Series
Lepage, M.-A., Rozza, N., Kremer, R., Grunbaum, A.
10.1101/2020.07.23.20153932 — Posted: 2020-07-27
SEIHCRD Model for COVID-19 spread scenarios, disease predictions and estimates the basic reproduction number, case fatality rate, hospital, and ICU beds requirement
Singh, A., Bajpai, M. K.
10.1101/2020.07.24.20161752 — Posted: 2020-07-27
Epidemiological investigation and prevention control analysis of longitudinal distribution of COVID-19 in Henan province, China
Yang, X., Chen, X., Ding, C., Bai, Z., Zhu, J., Sun, G., Yu, G.
10.1101/2020.07.25.20161844 — Posted: 2020-07-27
Associations of severe COVID-19 with polypharmacy in the REACT-SCOT case-control study
McKeigue, P. M., Kennedy, S., Weir, A., Bishop, J., McGurnaghan, S. J., McAllister, D., Robertson, C., Wood, R., Lone, N., Murray, J., Caparrotta, T. M., Smith-Palmer, A., Goldberg, D., McMenamin, J., Ramsay, C., Guthrie, B., Hutchinson, S., Colhoun, H. M.
10.1101/2020.07.23.20160747 — Posted: 2020-07-27 Discussion: Onsite
Functional mapping of B-cell linear epitopes 1 of SARS-CoV-2 in COVID-19 convalescent population
Yi, Z., Ling, Y., Zhang, X., Chen, J., Hu, K., Wang, Y., Song, W., Ying, T., Zhang, R., Lu, H., Yuan, Z.
10.1101/2020.07.25.20161869 — Posted: 2020-07-27
Adapting for the COVID-19 pandemic in Ecuador, a characterization of hospital strategies and patients
Garzon-Chavez, D., Romero-Alvarez, D., Bonifaz, M., Gaviria, J., Mero, D., Gunsha, N., Perez, A., Garcia, M., Espejo, H., Espinosa, F., Ligna, E., Espinel, M., Quentin, E., Teran, E., Mora, F., Reyes, J.
10.1101/2020.07.25.20161661 — Posted: 2020-07-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).